Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17776277 | 0.97 | TSHR (0.39) | TSHRGSTP1 | |
| SCHEMBL31616445 | 0.97 | TSHR (0.39) | TSHRGSTP1 | |
| SCHEMBL17793345 | 0.97 | TSHR (0.39) | TSHRGSTP1 | |
| SCHEMBL12092218 | 0.97 | TSHR (0.39) | TSHRGSTP1 | |
| SCHEMBL12092185 | 0.97 | TSHR (0.39) | TSHRGSTP1 | |
| SCHEMBL24894194 | 0.97 | TSHR (0.39) | TSHRGSTP1 | |
| SCHEMBL19727005 | 0.90 | TSHR (0.36) | TSHR | |
| SCHEMBL31656393 | 0.85 | TSHR (0.36) | TSHR | |
| SCHEMBL27252354 | 0.85 | TSHR (0.36) | TSHR | |
| SCHEMBL12092217 | 0.85 | PSMB8 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 213 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114578043-B | ELISA kit, preparation method and detection method thereof | 伊莱瑞特(武汉)生物技术有限公司 | 2024-08-20 | — | — | CN | claimed |
| CN-116392580-A | Type 1 diabetes multi-antigen vaccine preparation and application thereof | 中国科学技术大学 | 2023-07-07 | — | — | CN | claimed |
| CN-115469102-A | Method for measuring glycosylated protein molecular weight | 深圳湾实验室 | 2022-12-13 | — | — | CN | claimed |
| CN-114578043-A | ELISA kit and preparation method and detection method thereof | 伊莱瑞特(武汉)生物技术有限公司 | 2022-06-03 | — | — | CN | claimed |
| US-11319533-B2 | CRISPR nanocomplex for nonviral genome editing and method for preparing the same | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2022-05-03 | — | — | US | claimed |
| CN-122070370-A | Multi-modal detection using extracellular vesicles | 仁慈生物分析公司 | 2026-05-19 | — | — | CN | disclosed |
| EP-4737574-A2 | POLY-TAILED AND POLY-CAPPED MRNA AND USES THEREOF | The Broad Institute Inc. (US) | 2026-05-06 | — | — | EP | disclosed |
| US-20260116914-A1 | METHODS OF GENERATING NANOARRAYS AND MICROARRAYS | NAUTILUS SUBSIDIARY INC (US) | 2026-04-30 | — | — | US | disclosed |
| US-20260115268-A1 | Heat-Stable Enterotoxins Mutants as Antidiarrheal Vaccine Antigens | VESTLANDETS INNOVASJONSSELSKAP AS (NO) | 2026-04-30 | — | — | US | disclosed |
| US-20260097138-A1 | BIOMATERIAL COATED NANOSTRUCTURES FOR PHOTOACOUSTIC IMAGING AND PHOTOTHERMAL THERAPY OF TUMOR LESIONS | OSPEDALE SAN RAFFAELE S.R.L. (IT) | 2026-04-09 | — | — | US | disclosed |
| EP-4196581-B1 | SEQUENTIAL ENCODING METHODS AND RELATED KITS | ENCODIA INC (US) | 2026-02-25 | — | — | EP | disclosed |
| US-12559745-B2 | Methods and compositions for linking RNA stem loops | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-02-24 | — | — | US | disclosed |
| US-20170205417-A1 | Labeling Reagent Containing A Molecularly Targeted Drug | Konica Minolta, Inc. (JP) | 2017-07-20 | — | — | US | disclosed |
| US-20170205417-A1 | Labeling Reagent Containing A Molecularly Targeted Drug | Konica Minolta, Inc. (JP) | 2017-07-20 | — | — | US | disclosed |
| EP-3173785-A1 | LABELING REAGENT CONTAINING A MOLECULARLY TARGETED DRUG | Konica Minolta, Inc. (JP) | 2017-05-31 | — | — | EP | disclosed |
| US-20170043024-A1 | BIOACTIVE CONJUGATES FOR OLIGONUCLEOTIDE DELIVERY | UNIVERSITY OF MASSACHUSETTS | 2017-02-16 | — | — | US | disclosed |
| US-20150320913-A1 | MULTI-FUNCTIONAL SURFACE COATING OF IMPLANTS | THE UNIVERSITY OF MASSACHUSETTS | 2015-11-12 | — | — | US | disclosed |
| US-8889623-B2 | Immunostimulatory nanoparticles and related compositions, methods and systems | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC (US) | 2014-11-18 | — | — | US | disclosed |
| US-20100221176-A1 | METHODS AND COMPOSITIONS FOR PROTEIN LABELLING | GENENTECH, INC. | 2010-09-02 | — | — | US | disclosed |
| US-20100092567-A1 | IMMUNOSTIMULATORY NANOPARTICLES AND RELATED COMPOSITIONS, METHODS AND SYSTEMS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2010-04-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170205417-A1 | Labeling Reagent Containing A Molecularly Targeted Drug | MKI67, CD68, ALK | TSHR 2232/4885GSTP1 1421/4885 |
| US-20260097138-A1 | BIOMATERIAL COATED NANOSTRUCTURES FOR PHOTOACOUSTIC IMAGING AND PHOTOTHERMAL THERAPY OF TUMOR LESIONS | CD44, EPCAM, SIGLEC9 | TSHR 265/4885GSTP1 1177/4885 |
| US-20260116914-A1 | METHODS OF GENERATING NANOARRAYS AND MICROARRAYS | SPPL2B, SNAP29, SPPL2A | TSHR 1914/4885GSTP1 4254/4885 |
| US-20260115268-A1 | Heat-Stable Enterotoxins Mutants as Antidiarrheal Vaccine Antigens | SCN8A, SCN9A, VIP | TSHR 2163/4885GSTP1 4461/4885 |
| US-20100221176-A1 | METHODS AND COMPOSITIONS FOR PROTEIN LABELLING | RAB5IF, RPS27A, PSMA6 | TSHR 2895/4885GSTP1 2739/4885 |
| US-20170043024-A1 | BIOACTIVE CONJUGATES FOR OLIGONUCLEOTIDE DELIVERY | DCLRE1B, RTCB, RNASE1 | TSHR 2127/4885GSTP1 3457/4885 |
| US-12559745-B2 | Methods and compositions for linking RNA stem loops | TRDMT1, NSUN3, TRMT1L | TSHR 1695/4885GSTP1 1436/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.